Optigenex FCF Conversion
FCF Conversion Rate (FCF/EBITDA) of Optigenex (OPGX) as of Jul 16, 2026.
Get this data via API
Financial Data API
FCF Conversion
0.00
Last updated:
FCF Conversion Rate (FCF/EBITDA) of Optigenex is 2026 0.00 . FCF Conversion Rate (FCF/EBITDA) of Optigenex was 2025 19.90 % . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Optigenex Stock analysis
What does Optigenex do? Optigenex Inc. is a US-based company that operates in the health and beauty industry. It was founded in 2004 by a team of experienced entrepreneurs from the healthcare sector. The company's business model focuses on the development and marketing of innovative products based on science, research, and technological advancements. Optigenex has three main divisions: health, wellness, and beauty, each offering a variety of products tailored to meet the specific needs and requirements of consumers. The products offered by Optigenex include dietary supplements, anti-aging products, cosmetics, skincare products, hair products, and general health and well-being products. All products are manufactured in the USA and undergo strict quality controls. Optigenex has received numerous awards and recognition for its products and services in recent years, and it takes pride in being known for its unique products and high quality standards in the industry. The company also places a strong emphasis on research and development, collaborating closely with experts and research institutions to constantly develop new innovations and improved products. Optigenex has an extensive research and development department dedicated solely to the development of new technologies, products, and services. A key component of Optigenex's business model is its partner program, which offers partners the opportunity to market and earn money from its products. The company has developed an extensive training program for its partners to ensure they have all the necessary information and knowledge to build a successful business. Optigenex aims to become a global company that offers its products and services worldwide. The company already has a strong presence in the US and some European countries, and it intends to expand its reach and establish a foothold in other regions of the world in the future. Overall, Optigenex is a leading company in the health and beauty industry. With a wide range of innovative products, a strong focus on research and development, and a dedicated team of professionals and partners, the company strives to maintain and expand its position as a market leader in the industry. Optigenex is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Optigenex stock
On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Optigenex since 2006 – with annual values, charts, and detailed analysis.
Access this data via the Eulerpool API
Cash Flow — Optigenex
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Optigenex
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth